Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy
{{output}}
Chimeric antigen receptor T-cell (CAR T-cell) therapy has changed the paradigm of management of non-Hodgkin's lymphoma (NHL) and Multiple Myeloma. Infection complications have emerged as a concern that can arise in the setting of therapy and lead to morbidity ... ...
